Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...

3 Value Stocks That Fall Short

September 28, 2026

Performance

52-Week Range 56.9% below 52-week high

21.87

21.4352W Low 50.7952W High

1 Week 5.6% below 1-week high

21.431W Low 23.171W High

Collegium Pharmaceutical, Inc. - Common Stock (COLL) traded between $21.43 and $50.79 over the past 52 weeks and last traded at $21.87, 56.9% below its 52-week high. Over the past week it ranged between $21.43 and $23.17.

Past 12 Months

-3.4%

-7.1%

-41.6%

-32.9%

-52.0%

-35.4%

1W -$0.76

1M -$1.66

3M -$15.60

6M -$10.72

YTD -$23.66

1Y -$11.96

COLL was -35.4% over the past year, -32.9% over six months, -52.0% year to date, -3.4% in the last week.

12 Months vs Market

COLL

-35.4%

DIA

+9.7%

SPY

+15.4%

QQQ

+24.4%

IWM

+14.8%

Over the past 12 months COLL returned -35.4% versus DIA (Dow) +9.7%, SPY (S&P 500) +15.4%, QQQ (Nasdaq 100) +24.4% and IWM (Russell 2000) +14.8%.

Volume & Liquidity 1.32× 3-mo avg

Today 975,372 3-mo avg 736.3K

843.1K

913.4K

736.3K

600.8K

YTD

571.6K

551.2K

COLL most recently traded 975,372 shares against a 3-month average daily volume of 736.3K.

More News

1 Oversold Stock Ready to Bounce Back and 2 We Find Risky

September 22, 2026

1 Cash-Producing Stock on Our Buy List and 2 That Underwhelm

September 21, 2026

Collegium Pharmaceutical (NASDAQ:COLL) Tumbles on Revenue Miss and Lowered Guidance ↗

August 06, 2026

Via Chartmill

Collegium to Participate in Upcoming Investor Conferences

September 08, 2026

Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Via The Motley Fool

Collegium Announces $50 Million Accelerated Share Repurchase Program

August 13, 2026

5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call

August 13, 2026

COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance

August 07, 2026

Collegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops

Collegium Pharmaceutical Q2 Earnings Call Highlights ↗

August 06, 2026

Via MarketBeat

August 06, 2026

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

August 06, 2026

Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect

August 04, 2026

Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks

July 23, 2026

Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026

July 23, 2026

Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston

July 20, 2026

1 Healthcare Stock with Competitive Advantages and 2 We Question

July 16, 2026

1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm

July 07, 2026

1 Mooning Stock to Own for Decades and 2 That Underwhelm

July 03, 2026

2 Profitable Stocks to Keep an Eye On and 1 We Brush Off

July 02, 2026

3 of Wall Street’s Favorite Stocks We Approach with Caution

June 19, 2026

Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 05, 2026

2 Reasons to Sell COLL and 1 Stock to Buy Instead

June 03, 2026

Collegium to Participate in 2026 Jefferies Global Healthcare Conference

May 27, 2026